Goldman Sachs
AVAH icon

Goldman Sachs’s Aveanna Healthcare AVAH Stock Holding History

Goldman Sachs’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.47M Buy
872,227
+117,531
+16% +$829K ﹤0.01% 3517
2026
Q1 		$4.86M Buy
754,696
+321,892
+74% +$2.49M ﹤0.01% 3720
2025
Q4 		$3.54M Sell
432,804
-98,450
-19% -$889K ﹤0.01% 4080
2025
Q3 		$4.71M Buy
531,254
+121,886
+30% +$771K ﹤0.01% 3700
2025
Q2 		$2.14M Buy
409,368
+69,515
+20% +$353K ﹤0.01% 4128
2025
Q1 		$1.84M Buy
339,853
+25,974
+8% +$123K ﹤0.01% 4227
2024
Q4 		$1.43M Buy
313,879
+107,406
+52% +$550K ﹤0.01% 4563
2024
Q3 		$1.07M Buy
206,473
+147,130
+248% +$665K ﹤0.01% 4586
2024
Q2 		$164K Buy
59,343
+15,591
+36% +$38.9K ﹤0.01% 5313
2024
Q1 		$109K Sell
43,752
-2,238
-5% -$5.4K ﹤0.01% 5236
2023
Q4 		$123K Sell
45,990
-3,088
-6% -$5.89K ﹤0.01% 5260
2023
Q3 		$58.4K Sell
49,078
-14,398
-23% -$22.3K ﹤0.01% 5259
2023
Q2 		$107K Sell
63,476
-3,649,853
-98% -$4.58M ﹤0.01% 5344
2023
Q1 		$3.86M Sell
3,713,329
-2,622,205
-41% -$3.12M ﹤0.01% 3292
2022
Q4 		$4.94M Buy
6,335,534
+6,217,787
+5,281% +$6.51M ﹤0.01% 3177
2022
Q3 		$177K Buy
117,747
+4,798
+4% +$9.86K ﹤0.01% 5523
2022
Q2 		$255K Sell
112,949
-271,205
-71% -$786K ﹤0.01% 5509
2022
Q1 		$1.31M Buy
384,154
+4,286
+1% +$23.3K ﹤0.01% 4605
2021
Q4 		$2.81M Buy
379,868
+91,056
+32% +$662K ﹤0.01% 3953
2021
Q3 		$2.32M Sell
288,812
-1,042
-0.4% -$10.1K ﹤0.01% 4057
2021
Q2 		$3.58M Buy
+289,854
New +$3.44M ﹤0.01% 3657

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs's AVAH Position: Q2 2026 in Review

Goldman Sachs increased its Aveanna Healthcare (AVAH) stake by 16% in Q2 2026, buying an estimated $829K and bringing the position to 872,227 shares worth $7.47M. The position accounts for ﹤0.01% of the portfolio, ranked #3517.

Goldman Sachs first reported a position in AVAH in Q2 2021 and has held it in 21 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Goldman Sachs held 872,227 shares of Aveanna Healthcare worth $7.47M as of Q2 2026.
  • Goldman Sachs bought 117,531 Aveanna Healthcare shares in Q2 2026, an estimated $829K.
  • Aveanna Healthcare made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3517 holding.
  • Goldman Sachs first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 21 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.